ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,ORAL USE,Y,N
2,1,ORAL USE,Y,N
3,1,ORAL USE,Y,S
4,1,ORAL USE,Y,N
5,1,ORAL USE,Y,S
6,1,ORAL USE,Y,N
7,1,ORAL USE,Y,S
8,1,ORAL USE,Y,S
9,1,ORAL USE,Y,N
10,1,ORAL USE,Y,S
11,1,ORAL USE,Y,S
